Navigation Links
WuXi PharmaTech Acquires China-Based Clinical Research Services Companies
Date:10/24/2011

SHANGHAI, Oct. 24, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development services company with operations in China and the United States, today announced the acquisition of MedKey Med-Tech Development Co. Ltd. and Jiecheng Med-Tech Development Co. Ltd., two related contract clinical research services companies based in Shanghai, China. The financial terms of the transaction were not disclosed.

Founded in 2006, MedKey/Jiecheng have about 80 employees and operate in 15 cities in China, with offices in Shanghai, Beijing, and Guangzhou. The companies provide services in regulatory affairs, Phase I-IV clinical trial management, and clinical trial site management throughout most of the regions in China. Their customer base includes both multinational pharmaceutical companies and domestic Chinese pharmaceutical companies. David Xi, founder, owner, and CEO of the companies, will continue to manage MedKey/Jiecheng as WuXi's Executive Director of Clinical Operations. As part of WuXi, MedKey/Jiecheng will leverage WuXi's broad customer base and will focus on clinical services needed by customers for Chinese regulatory filings and market access.    

"WuXi's acquisition of Medkey/Jiecheng continues our strategy to build an integrated platform of R&D services that will allow anyone and any company to discover and develop drugs more efficiently and cost effectively for patients," said Dr. Ge Li, Chairman and CEO of WuXi. "This acquisition provides WuXi an existing clinical development service capability and infrastructure that WuXi will expand and strengthen to serve our customers' growing clinical development needs in the fast-growing Chinese healthcare market."    

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnolog
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. WuXi PharmaTech Announces Second Quarter 2011 Results
2. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
3. WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release
4. WuXi PharmaTech Announces First-Quarter 2011 Results
5. WuXi PharmaTech Files 2010 Annual Report on Form 20-F
6. WuXi PharmaTech Schedules First-Quarter 2011 Earnings Release
7. Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
8. WuXi PharmaTech Schedules Fourth-Quarter 2010 Earnings Release
9. WuXi PharmaTech Provides Update of 2010 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
10. WuXi PharmaTech Presents 2010 Life Science and Chemistry Awards
11. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... According to a new market ... Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices ... WPW) - Global Forecasts to 2019 ", published by MarketsandMarkets, ... ~$4.73 Billion by 2019 with a CAGR of around ... Browse   90   ma rket ...
(Date:3/27/2015)... , March 27, 2015 The International Myeloma ... myeloma patients while working toward prevention and a cure ... for introducing a federal resolution (H. Res. 174) that ... as "National Multiple Myeloma Awareness Month." Currently ... worldwide, and more than 110,000 new cases are diagnosed ...
(Date:3/27/2015)... , March 27, 2015  RXi ... privately-held MirImmune LLC, today announced that they ... to RXi,s novel and proprietary sd-rxRNA® technology ... immunotherapies. The collaboration has the potential to ... friendly cancer treatments that could be a ...
Breaking Medicine Technology:Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... new Mayo,Clinic study found that regular physical exercise ... of the brain that affects nerve cells,involved in ... the,American Academy of Neurology Annual Meeting in Chicago ... impairment can function reasonably well,in everyday activities, but ...
... IND Filing for Novavax,s ... Seasonal Influenza Vaccine Candidate, ROCKVILLE, Md., April 16 ... has received positive results from an,immunogenicity study in ferrets inoculated ... enable Novavax to,complete its planned investigational new drug ("IND") application ...
Cached Medicine Technology:Mayo Clinic Finds Exercise Can Reduce the Risk of Mild Cognitive Impairment 2Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate 2Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate 3
(Date:3/27/2015)... TX (PRWEB) March 27, 2015 The ... is an essential source of information on and analysis ... US. The population of the US in 2013 amounted ... Growth Rate (CAGR) of 0.8% from 2008. The country’s ... of chronic diseases will help to boost the growth ...
(Date:3/27/2015)... Naples, FL and London, UK (PRWEB) March 27, 2015 ... solution, announced today that it has appointed Sean Fitzgerald, ... the role of Chief Operating Officer and Interim Chief ... Vice President of leading education technology innovator, EverFi, backed ... Eric Schmidt, and Twitter founder Evan Williams. Prior to ...
(Date:3/27/2015)... GrassrootsHealth, an international nonprofit public health ... NOW! vitamin D demonstration project April 7 in the ... (MUSC), and will soon follow with a second phase ... to a minimum of 500 pregnant women at 17 ... service areas. The project will include patient and health ...
(Date:3/27/2015)... 2015 When struck with the aftermath ... know where to begin. The latest eBook released ... attorney, offers accident victims a clear and concise process ... ensure their personal injury claim is seen through to ... first actions that should be taken immediately following the ...
(Date:3/27/2015)... Trail mix is the perfect, healthy snack ... hikes and during the game! It’s portable, lightweight and provides ... to introduce a new line of specialty trail mixes that ... flavorful selections packed with nutritious, 100% all natural ingredients. , ... that add protein and fiber to your diet and boost ...
Breaking Medicine News(10 mins):Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 4Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2
... Older adults who don,t get enough vitamin D ... at increased risk of developing mobility limitations and disability, according ... "This is one of the first studies to look at ... mobility limitations or disability in older adults," said lead author ...
... been approved since March 2011 in men with metastatic ... with hormone blockers and have already been pre-treated with ... pursuant to the "Act on the Reform of the ... Quality and Efficiency in Health Care (IQWiG) examined whether ...
... of Physicians (ACP), the second-largest physician group in the United ... aims to prevent one million heart attacks and strokes in ... Empowering Americans to make healthy choices such as preventing ... can reduce the number of people who need medical treatment ...
... Vitamin D deficiency is not healthy. However, new research from ... level of the essential vitamin is not good either. The ... results have just been published in the reputed scientific ... is instrumental in helping calcium reach our bones, thus lessening ...
... aspirin and other similar painkillers may help protect against ... a peer-reviewed journal of the American Cancer Society, the ... to the benefits of these commonly used medications. ... NSAIDs, which include aspirin, ibuprofen, and naproxen, as well ...
... Aggressive efforts to lower blood pressure in people with ... a new study The research shows that there ... with diabetes in the U.S. Department of Veterans Affairs, with ... controlled and 94 percent getting appropriate BP treatment. ...
Cached Medicine News:Health News:Older adults may need more vitamin D to prevent mobility difficulties 2Health News:Cabazitaxel can offer an advantage in certain patients 2Health News:Cabazitaxel can offer an advantage in certain patients 3Health News:ACP joins Million Hearts to help save lives from preventable heart attacks and strokes 2Health News:Too much vitamin D can be as unhealthy as too little 2Health News:Commonly used painkillers may protect against skin cancer 2Health News:1 size doesn't fit all when treating blood pressure in people with diabetes, VA/U-M study suggests 2Health News:1 size doesn't fit all when treating blood pressure in people with diabetes, VA/U-M study suggests 3
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... SEDIPLAST® is a completely closed system ... laboratory personnel from the risk associated ... uniquely designed erythrocyte sedimentation rate test ... convenience as well as reliable and ...
... Unlike other ESR products, SEDIPLAST® is ... design features to protect laboratory personnel ... handling. SEDIPLAST® is a uniquely designed ... provides greater safety and convenience as ...
... The use of guaiac as ... of blood is based on ... present in guaiac to quinones, ... a blue color. If blood ...
Medicine Products: